| 1. |
- Micah, Angela E., et al.
(författare)
-
Tracking development assistance for health and for COVID-19 : a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050
- 2021
-
Ingår i: The Lancet. - : Elsevier. - 0140-6736 .- 1474-547X. ; 398:10308, s. 1317-1343
-
Forskningsöversikt (refereegranskat)abstract
- Background The rapid spread of COVID-19 renewed the focus on how health systems across the globe are financed, especially during public health emergencies. Development assistance is an important source of health financing in many low-income countries, yet little is known about how much of this funding was disbursed for COVID-19. We aimed to put development assistance for health for COVID-19 in the context of broader trends in global health financing, and to estimate total health spending from 1995 to 2050 and development assistance for COVID-19 in 2020. Methods We estimated domestic health spending and development assistance for health to generate total health-sector spending estimates for 204 countries and territories. We leveraged data from the WHO Global Health Expenditure Database to produce estimates of domestic health spending. To generate estimates for development assistance for health, we relied on project-level disbursement data from the major international development agencies' online databases and annual financial statements and reports for information on income sources. To adjust our estimates for 2020 to include disbursements related to COVID-19, we extracted project data on commitments and disbursements from a broader set of databases (because not all of the data sources used to estimate the historical series extend to 2020), including the UN Office of Humanitarian Assistance Financial Tracking Service and the International Aid Transparency Initiative. We reported all the historic and future spending estimates in inflation-adjusted 2020 US$, 2020 US$ per capita, purchasing-power parity-adjusted US$ per capita, and as a proportion of gross domestic product. We used various models to generate future health spending to 2050. Findings In 2019, health spending globally reached $8. 8 trillion (95% uncertainty interval [UI] 8.7-8.8) or $1132 (1119-1143) per person. Spending on health varied within and across income groups and geographical regions. Of this total, $40.4 billion (0.5%, 95% UI 0.5-0.5) was development assistance for health provided to low-income and middle-income countries, which made up 24.6% (UI 24.0-25.1) of total spending in low-income countries. We estimate that $54.8 billion in development assistance for health was disbursed in 2020. Of this, $13.7 billion was targeted toward the COVID-19 health response. $12.3 billion was newly committed and $1.4 billion was repurposed from existing health projects. $3.1 billion (22.4%) of the funds focused on country-level coordination and $2.4 billion (17.9%) was for supply chain and logistics. Only $714.4 million (7.7%) of COVID-19 development assistance for health went to Latin America, despite this region reporting 34.3% of total recorded COVID-19 deaths in low-income or middle-income countries in 2020. Spending on health is expected to rise to $1519 (1448-1591) per person in 2050, although spending across countries is expected to remain varied. Interpretation Global health spending is expected to continue to grow, but remain unequally distributed between countries. We estimate that development organisations substantially increased the amount of development assistance for health provided in 2020. Continued efforts are needed to raise sufficient resources to mitigate the pandemic for the most vulnerable, and to help curtail the pandemic for all. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.
|
|
| 2. |
- Sbarra, AN, et al.
(författare)
-
Mapping routine measles vaccination in low- and middle-income countries
- 2021
-
Ingår i: Nature. - : Springer Science and Business Media LLC. - 1476-4687 .- 0028-0836. ; 589:7842, s. 415-
-
Tidskriftsartikel (refereegranskat)abstract
- The safe, highly effective measles vaccine has been recommended globally since 1974, yet in 2017 there were more than 17 million cases of measles and 83,400 deaths in children under 5 years old, and more than 99% of both occurred in low- and middle-income countries (LMICs)1–4. Globally comparable, annual, local estimates of routine first-dose measles-containing vaccine (MCV1) coverage are critical for understanding geographically precise immunity patterns, progress towards the targets of the Global Vaccine Action Plan (GVAP), and high-risk areas amid disruptions to vaccination programmes caused by coronavirus disease 2019 (COVID-19)5–8. Here we generated annual estimates of routine childhood MCV1 coverage at 5 × 5-km2pixel and second administrative levels from 2000 to 2019 in 101 LMICs, quantified geographical inequality and assessed vaccination status by geographical remoteness. After widespread MCV1 gains from 2000 to 2010, coverage regressed in more than half of the districts between 2010 and 2019, leaving many LMICs far from the GVAP goal of 80% coverage in all districts by 2019. MCV1 coverage was lower in rural than in urban locations, although a larger proportion of unvaccinated children overall lived in urban locations; strategies to provide essential vaccination services should address both geographical contexts. These results provide a tool for decision-makers to strengthen routine MCV1 immunization programmes and provide equitable disease protection for all children.
|
|
| 3. |
- Bahadorikhalili, Saeed, et al.
(författare)
-
N-sulfonyl ketenimine as a versatile intermediate for the synthesis of heteroatom containing compounds
- 2021
-
Ingår i: Journal of Organometallic Chemistry. - : Elsevier. - 0022-328X .- 1872-8561. ; 939
-
Forskningsöversikt (refereegranskat)abstract
- The introduction of more facile and atom efficient methods for the synthesis of organic linear and cyclic compounds is the aim of various researchers worldwide. N-sulfonyl ketenimine is an interesting intermediate in modern organic synthesis. N-sulfonyl ketenimine is capable of selective production of various heteroatom containing compounds, based on the functional groups in the structure of this intermediate. Several linear and cyclic compounds are synthesized from this intermediate. In this review, the role of N-sulfonyl ketenimine is studied as an intermediate in several organic syntheses.
|
|
| 4. |
- Mahdavi-Meymand, Amin, et al.
(författare)
-
Challenging soft computing optimization approaches in modeling complex hydraulic phenomenon of aeration process
- 2021
-
Ingår i: ISH Journal of Hydraulic Engineering. - : Informa UK Limited. - 2164-3040 .- 0971-5010. ; 27:sup1, s. 58-69
-
Tidskriftsartikel (refereegranskat)abstract
- This study investigates and challenges the capability of standard and hybrid soft computing models of fuzzy c-means clustering adaptive neuro-fuzzy inference system (ANFIS), wavenet and artificial neural networks (MLPNN and RBFNN) to estimate the spillway aerator air demand in dams. For the learning process, four different meta-heuristic optimization methods (particle swarm optimization (PSO), genetic algorithm (GA), firefly algorithm (FA) and biogeography-based optimization (BBO)) are considered as alternatives to the classical optimization algorithms of the data-driven models. In addition to the data-driven models, the multiple linear regressions and some empirical relations are used to evaluate the performance of the models. Evaluation of the models is assessed with five different statistical parameters as well as the diagnostic tool of the Taylor’s diagram. Analysis of the models’ outcome reveals that the ANFIS-GA has the best performance associated with a standard root mean square error of 0.309 and a coefficient of determination (R 2 ) of 0.93.
|
|
| 5. |
|
|
